ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 66 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $628,500 | +452.2% | 203,398 | +361.0% | 0.00% | – |
Q1 2024 | $113,827 | -52.8% | 44,119 | -54.3% | 0.00% | – |
Q4 2023 | $241,272 | -41.6% | 96,509 | -29.2% | 0.00% | – |
Q1 2023 | $412,952 | +66.3% | 136,288 | +27.9% | 0.00% | – |
Q4 2022 | $248,253 | +589.6% | 106,546 | +464.7% | 0.00% | – |
Q3 2022 | $36,000 | -68.7% | 18,869 | -55.7% | 0.00% | – |
Q2 2022 | $115,000 | -91.1% | 42,601 | -90.2% | 0.00% | – |
Q1 2022 | $1,296,000 | -60.6% | 434,714 | -48.6% | 0.00% | – |
Q4 2021 | $3,293,000 | +66.6% | 846,380 | +83.7% | 0.00% | – |
Q3 2021 | $1,977,000 | +924.4% | 460,861 | +624.2% | 0.00% | – |
Q2 2021 | $193,000 | -63.8% | 63,635 | -60.3% | 0.00% | – |
Q1 2021 | $533,000 | -45.1% | 160,362 | -41.4% | 0.00% | – |
Q4 2020 | $971,000 | +1732.1% | 273,464 | +1525.3% | 0.00% | – |
Q3 2020 | $53,000 | -72.7% | 16,825 | -84.2% | 0.00% | – |
Q2 2020 | $194,000 | +165.8% | 106,181 | +45.6% | 0.00% | – |
Q1 2020 | $73,000 | -79.0% | 72,925 | -56.4% | 0.00% | -100.0% |
Q2 2019 | $348,000 | +411.8% | 167,188 | +1422.2% | 0.00% | – |
Q3 2017 | $68,000 | -56.1% | 10,983 | -56.7% | 0.00% | -100.0% |
Q3 2015 | $155,000 | – | 25,374 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
QVT Financial LP | 16,013,540 | $39,233,000 | 1.19% |
ARMISTICE CAPITAL, LLC | 1,940,000 | $4,753,000 | 1.12% |
DAFNA Capital Management LLC | 234,000 | $573,000 | 0.50% |
Alpha Wave Global, LP | 1,655,162 | $4,055,000 | 0.43% |
Telemetry Investments, L.L.C. | 150,000 | $368,000 | 0.21% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 5,294,945 | $12,972,000 | 0.18% |
SABBY MANAGEMENT, LLC | 792,617 | $1,942,000 | 0.11% |
K2 PRINCIPAL FUND, L.P. | 443,887 | $1,088,000 | 0.10% |
Anson Funds Management LP | 105,085 | $257,000 | 0.08% |
DIALECTIC CAPITAL MANAGEMENT, LP | 25,000 | $61,000 | 0.03% |